Monthly IV drug aims to slash infection risk in blood cancer patients
Prevention
Recruiting now
This study tests whether a monthly IV infusion of Gamunex-C, given alongside standard medical care, can reduce serious infections in people with chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma. About 49 participants will receive 13 doses over one year. The…
Phase: PHASE3 • Sponsor: Grifols Biologicals, LLC • Aim: Prevention
Last updated May 15, 2026 11:56 UTC